In summary, downregulated CYLD may be involved in the pathogenesis of inflammation in the RA synovium by regulating classical NF-κB activation, as well as in the pro-inflammatory effects and hyperproliferation of RA-FLSs. Here, CYLD is linked to rheumatoid arthritis.